Longitudinal Progression of Dysphagia in Huntington’s Disease and Dentatorubral-Pallidoluysian Atrophy: ≥10 Years Retrospection in Twelve Patients
Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2018, Vol 9, Issue 4
Abstract
Huntington's disease (HD) and Dentatorubral-pallidoluysian atrophy (DRPLA) are progressive and currently incurable neurodegenerative diseases which shares common features such as choreic involuntary movements, dementia, psychosis, and pathologic expansion of triplet nucleotide repeats in the causative genes [1,2]. In HD, the prevalence of dysphagia is approximately 30 % and several reports have been examined the features [3-5]. In DRPLA, dysphagia can be clinically challenging considering a report that approximately 50 % of the DRPLA patients decease by aspiration pneumonia [6]. However, the data is scarce about the natural course of dysphagia in both HD and DRPLA in long term. Thereby, we examined the progression to clarify the features and to seek clues for potential treatments. Introduction We performed a retrospective chart-review of patients with HD (N=7) and DRPLA (N=5) whose swallowing function was examined at least once in our institution. The diagnosis of HD was made by simultaneous presence of following three features; a) Triad of movement abnormality (i.e. involuntary movement, especially chorea, and/or bradykinesia), cognitive dysfunction, and psychiatric symptoms, b) Atrophy of caudate in brain imaging, and c) Pathologic expansion of CAG repeats in HTT in their own or their families; if gene testing not done, presence of both (a) and (b) in their family members. DRPLA was diagnosed by; a) characteristic neurological symptoms/signs (e.g. chorea, epilepsy, ataxia, and psyhosis), b) atrophy of brainstem and/or cerebellum, with or without leukoencephalopathy in brain imaging, and c) mutation of ATN1 or family history, in the same way as HD above. The chart-review was concluded if the patients deceased, transferred to other institutions, or received percutaneous endoscopic gastrostomy (PEG). The onset of disease was defined as the initiation of movement abnormality, excluding the start of congnitive-psychiatric symptoms or epilepsy. The level of nutritional modification was reviewed to express the severity of dysphagia in the following five stages (the mildest: I, the severest: V); (I) unmodified, (II) partially modified (e.g. particular foods were minced), (III) pasted, (IV) high-caloric jelly, and (V) enteral feeding via PEG. The activity in daily lives (ADL), when they became wheelchair-bound and/or bedridden, was reviewed to express the systemic motor function. The result of video fluorography (VF), using liquid barium, was also reviewed. Owing to the small sample size, the continuous variables were expressed in median (range). Results n the background of HD (case 1-7) and DRPLA (case 8-12), the age at disease onset was 49 (26-57) and 27(10-38) year-old (yo), the disease duration was 19 (10-29) and 17 (12-25) year in the last examination, respectively (Table 1). All had involuntary movements, prevalently chorea. For the preceding non-motor symptoms, case 5 had cognitive decline and case 8, 10, and 12 had epilepsy. As the endpoints, case 2 and 12 deceased, case 3 transferred to another institution, case 4, 7, 8, 10, and 11 received PEG, and the rest survived by oral intake. If the data was missing or the test was not done, it was described as no data (ND), and pathological expansion of the triplet repeats without precise repeat number was described as Exp in Table 1. All of the gene mutation was heterozygous. 6 patients took haloperidol with the dose (mg/ day) of 4.5 in case 1, 3.0 in case 2, 4.5 in case 3, 0.375 in case 5, 1.5 in case 6, 1.0 in case 10. As to dysphagia, two (28.6 %) of HD and two (40 %) of DRPLA received PEG due to the disease progression in ≥10 year or longer disease duration, while case 11 received PEG due to brain infarction (annotated by * in Table 1).
Authors and Affiliations
Hiroyuki Todo, Kengo Hasegawa, Keisuke Nishimoto, Katsuya Nishida, Naonobu Futamura, Itaru Funakawa
Keywords
Related Articles
- EP ID EP588444
- DOI 10.26717/BJSTR.2018.09.001833
- Views 158
- Downloads 0
Assessment of Microbial Contamination if “As Received”and “Bench-Top Exposed” Orthodontic Materials: A VitroMicrobiologic Investigation
Introduction: The assumption of sterility of packed materials used in orthodontics may lead practitioners to use them without the necessary sterilization. Hence, this study was undertaken to assess the microbial contamin...
Microspheres for Cosmetic and Medical Injections Must be Free of Phagocytosable Microparticles under 20 Microns
A more serious complication after the injection of all dermal fillers is the late occurrence of foreign body granulomas. The reason must be the retention of a foreign material in the memory of the macrophages, which like...
Can a Nasogastric Tube be Seen As the First Option When Children Intake Peg Prior to Colonoscopy?
According to ESPGHAN, polyethylene glycol with electrolytes (PEG) is generally the recommended laxative for bowel cleansing prior to colonoscopy in children owing to cleansing quality and safety [1]. Children with variou...
Giant Retroperitoneal Schwannoma: A Case Treated with 3D Laparoscopic Resection
Background: Schwannomas which are derived from Schwann cell and strictly found in head or neck region, upper and lower limbs. Retroperitoneal location accounts for less than 3% of primary schwannoma. W...
Can Aerobic Training Restore the Vascular Dysfunction Induced by Intrauterine Growth Restriction? Evidences from Experimental Studies
Aerobic training is used as a non-pharmacological treatment to improve vascular function in cardiometabolic conditions, but its potential effects in minimize the deleterious adaptations induced by IUGR in log-term are po...